21st Jun 2010 10:41
Among the companies expected to actively trade in Monday's session are Anadarko Petroleum Corp. (APC), BP PLC (BP, BP.LN) and CNB Financial Corp. (CCNE). Anadarko late Friday called the oil spill in the Gulf of Mexico "preventable and the direct result of BP's reckless decisions and actions," a
Read more21st Jun 2010 10:41
By Steve Goldstein U.S. stock futures, Chinese airlines and natural resource companies led a global advance in equities and commodities markets Monday after China said it would lift the lid on its tightly-controlled currency, spurring expectations for growth in the world's third largest economy
Read more18th Jun 2010 22:17
DOW JONES NEWSWIRES AstraZeneca PLC (AZN) said it would settle a class-action suit over its pricing for wholesale drugs for $103 million even though it believes its pricing and marketing practices were lawful. The suit claimed the company inflated the average wholesale price of expensive dr
Read more17th Jun 2010 16:46
London's blue chips rose for the seventh day running as BP took some comfort from the $20bn deal agreed with US president Obama. Banks also rallied on the new plans for City regulation set out yesterday. This afternoon, the coalition government also axed 12 projects costing £2bn, suspended another
Read more17th Jun 2010 14:12
Leading shares saw their gains trimmed over the lunch time session, despite expectations of a firm start on Wall Street. BP and the banks continue to lead the market higher. Under fire oil giant BP remains the top performer after yesterday's meeting between BP officials and the US president. BP h
Read more17th Jun 2010 12:05
BP and the banks are leading the market higher, with the latter in demand after concerns over Spain's ability to raise money on the bond markets were eased by the latest Spanish bond auction, which saw a higher level of demand than the March offering. Royal Bank of Scotland, Lloyds Banking and Bar
Read more17th Jun 2010 08:29
BP is leading London's blue chips higher in early dealings on Thursday following yesterday's meeting with the US president. BP has cancelled dividends for the rest of the year and agreed to a demand from US president Obama to put $20bn in an escrow account to cover claims resulting from the oil spi
Read more17th Jun 2010 08:25
LONDON (Dow Jones)--AstraZeneca PLC (AZN.LN), said Thursday that it purchased for cancellation 210,000 ordinary shares at a price of 3065 pence per share. MAIN FACTS: -Upon the cancellation of these shares, the number of shares in issue will be 1,441,169,972. Shares at 0725 GMT down 0.5
Read more17th Jun 2010 07:26
The Federal Court of Canada has blocked drugs giant AstraZeneca's attempt to delay the launch of a generic version of Astra's gastrointestinal disease treatment, Nexium. The court dismissed the drug company's request to prohibit the Canadian Minister of Health from issuing a Notice of Compliance (N
Read more17th Jun 2010 07:12
LONDON (Dow Jones)--Pharmaceutical giant AstraZeneca PLC (AZN.LN) said Thursday the Federal Court of Canada has dismissed its request to prohibit the Canadian Minister of Health from issuing a Notice of Compliance, or NOC, for the regulatory applications for generic esomeprazole magnesium submitted
Read more16th Jun 2010 11:00
(Adds analyst comment, share price) By Jason Douglas Of DOW JONES NEWSWIRES LONDON (Dow Jones)--U.K. medical technology company Biocompatibles International PLC (BII.LN) said Wednesday it will report a profit for the first six months of 2010 following strong sales of its drug-eluting bea
Read more16th Jun 2010 09:53
0853 GMT [Dow Jones] UBS upgrades the European ex-UK tech hardware sector to overweight from underweight, given attractive valuations. Says relative earnings momentum is already at a record low, and "it is hard to see it getting much worse." Also upgrades software to overweight from neutral, as a pl
Read more16th Jun 2010 08:27
LONDON (Dow Jones)--AstraZeneca PLC (AZN.LN), said Wednesday that it purchased for cancellation 310,000 ordinary shares at a price of 3058 pence per share. MAIN FACTS: -Upon the cancellation of these shares, the number of shares in issue will be 1,441,379,972. Shares at 0725 GMT down 23
Read more14th Jun 2010 13:03
(This article was originally published Sunday.) By Peter Loftus Of DOW JONES NEWSWIRES A new study found that a popular class of anti-hypertension drugs--including those made by Boehringer Ingelheim GmbH, Merck & Co. (MRK) and Novartis AG (NVS, NOVN.VX)--is associated with a modestly in
Read more13th Jun 2010 23:30
By Peter Loftus Of DOW JONES NEWSWIRES A new study found that a popular class of anti-hypertension drugs--including those made by Boehringer Ingelheim GmbH, Merck & Co. (MRK) and Novartis AG (NVS, NOVN.VX)--is associated with a modestly increased risk of cancer. The researchers cautioned
Read more